Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenario.

导出 LinkOut

翻译打印收藏纠错

作者： Daniele Roberto,Giacobbe ^[1] ; Lorenzo,Ball ^[2] ; Laura,Magnasco ^[3] ; Chiara,Dentone ^[4] ; Denise,Battaglini ^[1] ; Chiara,Robba ^[1] ; Paolo,Pelosi ^[3] ; Matteo,Bassetti ^[5]

作者单位： Infectious Diseases Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, 16132 Genoa, Italy. ^[1] Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy. ^[2] Anesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neuroscience, 16132 Genoa, Italy. ^[3] Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, 16132 Genoa, Italy. ^[4] Department of Medicine, University of Barcelona, 08007 Barcelona, Spain. ^[5]

主题词佐剂, 免疫(Adjuvants, Immunologic);消炎药(Anti-Inflammatory Agents);细菌感染(Bacterial Infections);危重病(Critical Illness);人类(Humans);炎症(Inflammation)

DOI 10.52586/4954

PMID 34590454

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in bioscience (Landmark edition)

2021年26卷9期

405-408页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenario.

Frontiers in bioscience (Landmark edition)

相似文献

Frontiers in bioscience (Landmark edition)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenario.

Frontiers in bioscience (Landmark edition)

相似文献

Frontiers in bioscience (Landmark edition)

相关期刊

检索历史清除